In summary, increased circulating concentrations of plasma ANP, which were correlated with a longer duration of DM, could precede the development of type 2 diabetic kidney disease with no noticeable cardiovascular disease, revealing one likely effect exerted by such bioactive peptides that could be useful in monitoring the DN development process in the early phase. This evidence concerns the gene NPPA and cardiovascular disorder.